Vir Biotechnology, Inc. VIR EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Vir Biotechnology, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s EBITDA margin?
- Vir Biotechnology, Inc. (VIR) reported EBITDA margin of -703% in Q1 2026.
- How has Vir Biotechnology, Inc.'s EBITDA margin changed year-over-year?
- Vir Biotechnology, Inc.'s EBITDA margin increased by 76.9% year-over-year, from -3,037.8% to -703%.
- What is the long-term trend for Vir Biotechnology, Inc.'s EBITDA margin?
- Over 4 years (2020 to 2025), Vir Biotechnology, Inc.'s EBITDA margin has grown at a 15.5% compound annual growth rate (CAGR), from -383.1% to -682.1%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.